If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHunting Regulatory News (HTG)

Share Price Information for Hunting (HTG)

Share Price is delayed by 15 minutes
Get Live Data
435.50    -9.50 (-2.13%)
Bid:
435.00
Ask:
440.50
Spread: 5.50 (1.264%)
Market Cap: £635.17m
HTG Live PriceLast checked at - London Stock Exchange

Intraday Hunting Share Chart

Transaction in Own Shares

30 Mar 2026 07:00

RNS Number : 5313Y
Hunting PLC
30 March 2026
 

For Immediate Release

30 March 2026

 

Hunting PLC

 

Transaction in own shares

 

Hunting PLC (the "Company") announces that, in accordance with the terms of its share buyback programme (the "Programme") announced on 17 March 2026, it has purchased the following number of its ordinary shares of 25 pence each ("Ordinary Shares") through Canaccord Genuity Limited for the period from 23 March 2026 to 27 March 2026.

 

Date of transaction:

Number of Shares repurchased:

Volume weighted average price paid (pence)

Lowest price paid per Share (pence):

Highest price paid per Share (pence):

23-Mar-26

13,500

467.25

458.32

472.50

24-Mar-26

13,500

477.15

474.30

480.00

25-Mar-26

13,500

484.06

483.50

485.00

26-Mar-26

13,500

499.50

499.50

499.50

27-Mar-26

12,800

487.64

482.40

491.00

 

The Company intends to cancel the purchased Ordinary Shares. Following cancellation, the Company will have 153,344,637 Ordinary Shares in issue.

 

Following cancellation, the total number of voting rights in the Company will be 153,344,637. This figure may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information please contact:

 

Hunting PLC

Tel: +44 (0) 20 7321 0123

Jim Johnson, Chief Executive

Bruce Ferguson, Finance Director

 

 

 

Sodali & Co (PR)

Tel: +44 (0) 79 3535 1934

James White

Pete Lambie

Tilly Abraham

 

 

 

Canaccord Genuity Limited (Broker)

Tel: +44 (0) 20 7523 8000

Henry Fitzgerald-O'Connor

George Grainger

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it is applied in the UK (the Market Abuse Regulation), a breakdown of trades made by Canaccord Genuity Limited for the period from 23 March 2026 to 27 March 2026 on behalf of the Company as part of the Programme on both an aggregate and individual trade basis is set out below:

 

Aggregate information: 

 

Venue

Volume Weighted Average Price

(pence per Ordinary Share)

Aggregated Volume

XLON

483.07

66,800

 

 Individual transactions:

 

Date of Transaction:

Transaction Time

Volume

Price per Ordinary Share (pence)

Trading Venue

Transaction Reference

23 March 2026

09:43:30

5,000

458.31595

XLON

00106463431TRLO1

23 March 2026

16:36:35

8,500

472.5

XLON

00106522775TRLO1

24 March 2026

13:13:02

6,750

474.3

XLON

00106551078TRLO1

24 March 2026

16:35:26

6,750

480

XLON

00106570880TRLO1

25 March 2026

14:35:20

5,000

485

XLON

00106604203TRLO1

25 March 2026

16:35:19

8,500

483.5

XLON

00106619552TRLO1

26 March 2026

16:36:58

13,500

499.5

XLON

00106665662TRLO1

27 March 2026

10:53:52

5,000

482.4

XLON

00106685340TRLO1

27 March 2026

16:36:06

7,800

491

XLON

00106717164TRLO1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBCGDXUXDDGLR
Date   Source Headline
24th Aug 20237:00 amRNSUnaudited results for the 6 months to 30 June 2023
13th Jul 20237:00 amRNSCollaboration Agreement with CRA-Tubulars BV
6th Jul 20237:00 amRNSH1 2023 Trading Update & CMD
26th Jun 202312:29 pmRNSStandard form for notification of major holdings
5th Jun 20237:00 amRNSStrategic Alliance
30th May 20237:00 amRNSMajor OCTG order & revised 2023 full year guidance
19th May 202312:29 pmRNSDirectors Shareholding/PDMR transactions
16th May 20233:32 pmRNSDirector Shareholding/PDMR
5th May 20237:00 amRNSDirector/PDMR Shareholding
2nd May 202310:05 amRNSTR-1: Notification of major holdings
27th Apr 20233:35 pmRNSPayment of 2022 Final Dividend in Sterling
27th Apr 202312:56 pmRNSDirector Shareholding/PDMR
26th Apr 202311:44 amRNSTR-1: Notification of Major Holdings
20th Apr 20232:36 pmRNSReport on Payments to Govts
19th Apr 202312:54 pmRNSResult of AGM
19th Apr 20237:00 amRNSAGM and Q1 2023 Trading Update
21st Mar 202312:00 pmRNSDirectors Shareholding/PDMR Replacement
16th Mar 20234:00 pmRNSAnnual Report and Accounts 2022 and Notice of AGM
10th Mar 20234:39 pmRNSDirectors Shareholding/PDMR transactions
9th Mar 20233:45 pmRNSDirectors Shareholding/PDMR
9th Mar 20233:39 pmRNSDirectors Shareholding/PDMR
3rd Mar 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Mar 20237:01 amRNSLaunch of 2030 Strategy & Capital Markets Day
2nd Mar 20237:00 amRNSResults for the year ended 31 December 2022
26th Jan 20236:00 pmRNSMicro Focus International
26th Jan 20234:58 pmRNSTR-1: Notification Of Major Holdings
17th Jan 20237:00 amRNSAppointment of Joint Corporate Broker
3rd Jan 20237:00 amRNSAppointment of non-executive Director
15th Dec 20227:00 amRNSYear-End Trading Update
2nd Nov 202211:18 amRNSDirector Shareholding/PDMR
2nd Nov 202211:17 amRNSDirector Shareholding/PDMR
2nd Nov 202211:16 amRNSDirector Shareholding/PDMR
27th Oct 20227:00 amRNSQ3 2022 Trading Update
14th Oct 20224:00 pmRNSPayment of 2022 Interim Dividend in Sterling
5th Oct 20223:44 pmRNSDirector Shareholding/PDMR
29th Sep 20224:14 pmRNSDirector Declaration
12th Sep 202212:42 pmRNSTR-1: Notification Of Major Holdings
6th Sep 202210:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
25th Aug 20227:01 amRNSTrading Update
25th Aug 20227:00 amRNSUnaudited results for the six months to 30/06/22
5th Jul 20221:10 pmRNSPDMR Shareholding
30th Jun 20227:00 amRNSH1 2022 Trading Update
24th Jun 20227:00 amRNSChange of Registered Office
29th Apr 20224:00 pmRNSReport on Payments to Governments
28th Apr 20222:29 pmRNSPayment of 2021 Final Dividend in Sterling
20th Apr 20222:40 pmRNSResults of AGM and Directorate Change
20th Apr 20227:00 amRNSAGM and Q1 2022 Trading Update
5th Apr 20221:29 pmRNSTR-1: Notification of major holdings
28th Mar 20229:34 amRNSHolding(s) in Company
23rd Mar 20222:30 pmRNSDirector Shareholding / PDMR Transactions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.